jhonny peralta getty

Let’s pump the brakes on the “PED use got Jhonny Peralta his big deal” talk

85 Comments

With a respectful nod to Ken Rosenthal, our own Bill Baer and the players who have taken to Twitter in the past couple of days to talk about Jhonny Peralta, may I ask why everyone seems to think that Peralta’s new contract represents some sort of problem with the drug penalty system in baseball and the incentives that flow therefrom? Because from where I’m sitting, it’s way more complicated than that.

I get the superficial appeal of the argument that goes “Peralta got busted for PEDs and then he gets a four-year, $52 million deal. What’s up with that?!” But that argument totally ignores the nature of the current free agent market to begin with.

Here’s a shocking idea: Jhonny Peralta got a big crazy free agent contract, not because he used PEDs, thereby messing up the incentive system, but because everyone in free agency is getting a big crazy free agent contract these days.

Those shaking their heads at Peralta say things like “clearly the current drug penalties are not hurting players’ market value.” But if you swap in phrases like “being hurt,” “being average” or “severely underperforming expectations” for “the current drug penalties” it explains current reality too. Dan Haren is coming off two injury-plagued and often ineffective years and he got $10 million. Jason Vargas got four-years, $32 million as a back-of-the-rotation starter. Tim Hudson has been pretty bad and got two-years, $23 million. Carlos Ruiz got three-years, $26 million. Why isn’t anyone talking about how their deals are confounding the incentive system that’s supposed to be in place?

Probably because they’re not. They’re getting what the market — currently flush with billions of dollars in new broadcast dollars and vanishingly small ways for teams to spend money on amateur and international signings — allows. Look around at the crop of shortstop talent in Major League Baseball at the moment and tell me that talent isn’t hard to come by. Then tell me that Peralta’s deal has more to do with him being a PED user than him simply being a good shortstop in a weak shortstop market who happened to hit free agency at the right time.

The fact that a team — a smart team, by the way — is spending serious money on Jhonny Peralta right now is because he’s in the market. Increase the ban to 100 games? Sure, maybe that would work for a guy whose ban coincided with his free agency, but it doesn’t always, or even often, work that way. Say a guy gets a ban in the second year of his three year deal, comes back in year three and plays well prior to becoming a free agent. Say a player tests positive in the spring of his walk year, serves his 100 games and then comes back in late July and lights it up just before free agency. You think those guys are not going to get paid the following offseason? Of course they are. Because they’ll be active players with marketable skills and teams like to give those guys lots of money.

The only way totally eliminate the idea of guys who take PEDs from later getting paid is to give permanent bans for first offenses. But of course that’s crazy. It’d be an ultra-extreme response to a problem that no one has demonstrated calls for such a solution and which would likely end the careers of some players based on false positives or inadvertent ingestion of PEDs. And no one who grouses about Jhonny Peralta allegedly screwing with the incentive system would ever seriously make that argument, would they? I seriously doubt it.

Peralta got paid because he’s a good player at a position with scant available talent in a market that is paying through the nose for even ordinary talent. If that’s troublesome to you, you have a lot of things to worry about besides whether 50-game suspensions are sufficient to deter PED use.

CC Sabathia: getting in shape and ready for baseball

sabathia getty
Leave a comment

CC Sabatha made headlines in October when he abruptly left the Yankees to go into alcohol rehab. After a month there he came back and gave interviews about his decision and his battle with the bottle and then disappeared into the offseason the way most players do.

He emerged the other day and spoke with the New York Daily News’ Mark Feinsand and says that he’s ready for baseball once again. Indeed, in some ways he’s more ready now than he usually is by mid February. He’s been throwing bullpen sessions for the past three weeks — he normally waits until he gets to Tamps — and he says his troublesome knee is feeling good.

 

Sabathia will turn 36 during the season. In 2015 he was 6-10 with a 4.73 ERA in 29 starts and posted his lowest strikeout rate in a decade. Late in the season, however, with the help of a knee brace, he was at his most effective in some time. He won’t need to return to 2008 form in order to help the Yankees this season, but he will need to look more like he did in September if he is to help the Yankees to the playoffs.

Jacob deGrom open to extension with Mets

New York Mets starting pitcher Jacob deGrom talks during media day for the Major League Baseball World Series against the Kansas City Royals Monday, Oct. 26, 2015, in Kansas City, Mo. (AP Photo/Charlie Riedel)
AP Photo/Charlie Riedel
1 Comment

The Mets are currently enjoying the spoils of the best young rotation in the game, but the big question is whether this is just a brief window or the start of sustained success. Given the huge prices on the free agent market, it’s going to be next to impossible to keep the band together, but at least one member of the rotation is open to sticking around for the long-term.

While there haven’t been any talks yet, All-Star right-hander Jacob deGrom told Kevin Kernan of the New York Post that he could see himself discussing an extension with the Mets.

“I’m a little bit older, so I might be more willing to do something like that,’’ deGrom told The Post at Mets pre-camp. “You just have to look at what is fair so both sides get a decent deal. It’s something I’d have to look into and make sure I agree with it.’’

It makes sense from deGrom’s perspective. He broke into the majors later than most prospects, so he’ll be 28 this June. Depending on whether he qualifies as a Super Two, he’ll be arbitration-eligible for the first time after either 2016 or 2017. Either way, he’s under team control through 2020, which means that he’s currently on track to hit free agency after his age-32 season. The market might not be kind to him even if he manages to stay healthy, so it could behoove him to get as much guaranteed money as possible right now. The Mets could always decide to play things year-to-year, but perhaps deGrom would be willing to settle for a discount in order to get them to buy out a free agent year or two. It’s a really interesting situation to think about, but odds are the two sides will wait on contract talks until he’s arbitration-eligible for the first time.

DeGrom owns a 2.61 ERA in 52 starts over his first two seasons in the majors. Among starters, only Zack Greinke, Jake Arrieta, and Clayton Kershaw have a lower ERA since the start of 2014.

Royals, Mike Moustakas avoid arbitration with two-year deal

Kansas City Royals' Mike Moustakas celebrates after hitting an RBI single against the Toronto Blue Jays during the eighth inning in Game 2 of baseball's American League Championship Seriesagainst the Toronto Blue Jays  on Saturday, Oct. 17, 2015, in Kansas City, Mo. (Nathan Denette/The Canadian Press via AP) MANDATORY CREDIT
Nathan Denette/The Canadian Press via AP
1 Comment

The Royals and third baseman Mike Moustakas have avoided arbitration by agreeing to a two-year, $14.3 million deal, reports Jon Heyman of MLB Network.

The deal, which was initially discussed last month, buys out Moustakas’ final two years of arbitration. Jeffrey Flanagan of MLB.com reports that it’s believed he’ll make $5.6 million in 2016 and $8.7 million in 2017.

The 27-year-old Moustakas posted an underwhelming .668 OPS over his first four seasons in the majors, but he enjoyed a big postseason in 2014 before breaking out last season by batting .284/.348/.470 with 22 home runs and 82 RBI.

Report: Rays having “advanced talks” with free agent reliever Tommy Hunter

Baltimore Orioles relief pitcher Tommy Hunter throws to the Miami Marlins during the seventh inning of a baseball game in Miami, Friday, May 22, 2015. (AP Photo/J Pat Carter)
AP Photo/J Pat Carter
1 Comment

ESPN’s Jerry Crasnick reported this morning that free agent reliever Tommy Hunter required core muscle repair surgery earlier this offseason. Coming off a disappointing 2015, it’s understandable why he’s still on the market, but it sounds like he has at least one significant lead.

Marc Topkin of the Tampa Bay Times hears that the Rays are having “advanced talks” with Hunter as they attempt to add an experienced arm to their bullpen. Nothing is considered close and Hunter is also talking to other clubs. Meanwhile, the Rays have been in touch with veteran reliever Ryan Webb while monitoring the trade market.

Hunter posted a 2.88 ERA as a late-inning arm from 2013-2014, but he compiled a mediocre 4.18 ERA over 58 appearances last season between the Orioles and Cubs. On the bright side, his velocity has held steady and his control is still very good. Despite the down year and core muscle surgery, Topkin writes that Hunter may be holding out for a multi-year deal.